Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...

The inaugural TCCI AI-Driven Science Symposium was held in San Francisco from Monday to Tuesday, bringing together three ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

Bill Gates's comments on genetics as "code" have reignited debate over genetic engineering, intellectual property, and the ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted ...

Signals from the plant cell wall help to orchestrate growth, reproduction and immune function. Can harnessing this molecular ...

A team of Northwestern investigators has discovered novel molecular underpinnings of a common oncogenic mutation in cancer, ...